We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
F icon
376
Ford
F
$60.9B
$5.54M 0.04%
391,575
+37,560
+11% +$511K
GM icon
377
General Motors
GM
$80.9B
$5.51M 0.04%
104,615
-5,900
-5% -$314K
VTEX icon
378
VTEX
VTEX
$767M
$5.49M 0.04%
+267,000
New +$6.66M
PVLA
379
Palvella Therapeutics
PVLA
$2.05B
$5.49M 0.04%
13,273
– –
MRSH
380
Marsh
MRSH
$94.3B
$5.47M 0.04%
36,157
-2,009
-5% -$304K
TFC icon
381
Truist Financial
TFC
$63.9B
$5.35M 0.04%
91,215
-2,045
-2% -$114K
TDOC icon
382
Teladoc Health
TDOC
$1.66B
$5.34M 0.04%
42,130
+4,206
+11% +$612K
DYN icon
383
Dyne Therapeutics
DYN
$4.15B
$5.25M 0.04%
323,393
– –
SNOW icon
384
Snowflake
SNOW
$98.1B
$5.17M 0.04%
17,106
-531
-3% -$151K
FISV
385
Fiserv Inc
FISV
$29.7B
$5.17M 0.04%
47,621
+2,126
+5% +$238K
M icon
386
Macy's
M
$6.51B
$5.14M 0.03%
+227,508
New +$4.55M
HSY icon
387
Hershey
HSY
$37.3B
$5.14M 0.03%
30,343
-1,590
-5% -$281K
BIDU icon
388
Baidu
BIDU
$35.7B
$5.11M 0.03%
33,248
-157,341
-83% -$25.8M
ASMB icon
389
Assembly Biosciences
ASMB
$498M
$5.11M 0.03%
122,404
+29,591
+32% +$1.24M
YMAB
390
DELISTED
Y-mAbs Therapeutics
YMAB
$5.08M 0.03%
178,181
– –
ODFL icon
391
Old Dominion Freight Line
ODFL
$46.3B
$5.07M 0.03%
35,450
+2,062
+6% +$286K
AXSM icon
392
Axsome Therapeutics
AXSM
$11.7B
$5.06M 0.03%
153,602
+35,000
+30% +$1.36M
USB icon
393
US Bancorp
USB
$97.9B
$5.04M 0.03%
84,742
-2,094
-2% -$119K
SRE icon
394
Sempra
SRE
$58.1B
$5.03M 0.03%
79,466
+3,264
+4% +$215K
RDUS
395
DELISTED
Radius Health, Inc.
RDUS
$5M 0.03%
403,068
– –
XP icon
396
XP
XP
$8.43B
$4.98M 0.03%
124,000
+74,000
+148% +$3.31M
SOLY
397
DELISTED
Soliton, Inc.
SOLY
$4.87M 0.03%
239,086
+171,316
+253% +$3.66M
BRKR icon
398
Bruker
BRKR
$9.4B
$4.85M 0.03%
62,128
– –
CME icon
399
CME Group
CME
$95.4B
$4.8M 0.03%
24,831
+553
+2% +$112K
DFS
400
DELISTED
Discover Financial Services
DFS
$4.8M 0.03%
39,053
+13,923
+55% +$1.75M
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.